Published in J Gastroenterol Hepatol on January 01, 1996
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut (2000) 2.33
Clinicopathological features and treatment of ectopic varices with portal hypertension. Int J Hepatol (2011) 1.87
Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol (2003) 1.38
Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int (2007) 1.24
The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J Gastroenterol (2007) 1.23
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut (2015) 1.20
Management of gastric fundal varices without gastro-renal shunt in 15 patients. World J Gastroenterol (2008) 1.19
Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices. World J Gastroenterol (2006) 1.16
The short-term effects of balloon-occluded retrograde transvenous obliteration, for treating gastric variceal bleeding, on portal hypertensive changes: a CT evaluation. Korean J Radiol (2007) 1.11
Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technical Results and Outcomes. Semin Intervent Radiol (2011) 1.08
Balloon-occluded retrograde transvenous obliteration for gastric varices: the relationship between the clinical outcome and gastrorenal shunt occlusion. BMC Med Imaging (2010) 0.98
Medical and endoscopic management of gastric varices. Semin Intervent Radiol (2011) 0.97
Transjugular Intrahepatic Portosystemic Shunt (TIPS) versus Balloon-occluded Retrograde Transvenous Obliteration (BRTO) for the Management of Gastric Varices. Semin Intervent Radiol (2011) 0.96
Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatol Int (2008) 0.96
Percutaneous transportal sclerotherapy with N-butyl-2-cyanoacrylate for gastric varices: technique and clinical efficacy. Korean J Radiol (2008) 0.93
Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis. Dig Dis Sci (2014) 0.89
Endovascular obliteration of bleeding duodenal varices in patients with liver cirrhosis. Eur Radiol (2005) 0.88
Duodenal variceal bleeding after balloon-occluded retrograde transverse obliteration: treatment with transjugular intrahepatic portosystemic shunt. World J Gastroenterol (2012) 0.86
Coil-Assisted Retrograde Transvenous Obliteration (CARTO) for the Treatment of Portal Hypertensive Variceal Bleeding: Preliminary Results. Clin Transl Gastroenterol (2014) 0.86
Gluing gastric varices in 2012: lessons learnt over 25 years. J Clin Exp Hepatol (2012) 0.86
Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol (2016) 0.85
Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study. Clin Mol Hepatol (2012) 0.85
Emergency balloon-occluded retrograde transvenous obliteration of ruptured gastric varices. World J Gastroenterol (2013) 0.84
New methods for the management of gastric varices. World J Gastroenterol (2006) 0.83
The History and Evolution of Balloon-occluded Retrograde Transvenous Obliteration (BRTO): From the United States to Japan and Back. Semin Intervent Radiol (2011) 0.83
Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Preprocedural Evaluation and Imaging. Semin Intervent Radiol (2011) 0.83
Short-term effects and early complications of balloon-occluded retrograde transvenous obliteration for gastric varices. ISRN Gastroenterol (2012) 0.82
Three benefits of microcatheters for retrograde transvenous obliteration of gastric varices. World J Gastroenterol (2012) 0.81
Thrombocytopenia in Patients with Gastric Varices and the Effect of Balloon-occluded Retrograde Transvenous Obliteration on the Platelet Count. J Clin Imaging Sci (2014) 0.81
Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO). Eur Radiol (2010) 0.80
Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension. J Gastroenterol (2013) 0.80
Management of gastric variceal bleeding: Role of endoscopy and endoscopic ultrasound. World J Hepatol (2014) 0.80
Echo-endoscopic analysis of variceal hemodynamics in patient with isolated gastric varices. Endosc Ultrasound (2014) 0.80
Transhepatic catheter-directed thrombolysis for portal vein thrombosis after partial splenic embolization in combination with balloon-occluded retrograde transvenous obliteration of splenorenal shunt. World J Gastroenterol (2006) 0.80
Variations of Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Balloon-occluded Antegrade Transvenous Obliteration (BATO) and Alternative/Adjunctive Routes for BRTO. Semin Intervent Radiol (2011) 0.79
Vascular plug-assisted retrograde transvenous obliteration of portosystemic shunts for refractory hepatic encephalopathy: a case report. Case Rep Radiol (2014) 0.79
Usefulness of microcatheters inserted overnight for additional injection of sclerosant after initial balloon-occluded retrograde transvenous obliteration of gastric varices. Case Rep Gastroenterol (2011) 0.79
Role of multi-detector row CT angiography in the management of gastric fundal varices. Gut (2004) 0.79
Development of thrombus in a systemic vein after balloon-occluded retrograde transvenous obliteration of gastric varices. Korean J Radiol (2012) 0.79
Spectrum of hepatofugal collateral pathways in portal hypertension: an illustrated radiological review. Insights Imaging (2015) 0.78
Management of gastric varices unsuccessfully treated by balloon-occluded retrograde transvenous obliteration: long-term follow-up and outcomes. ScientificWorldJournal (2013) 0.78
Balloon-occluded retrograde transvenous obliteration of gastric varices: concept, basic techniques, and outcomes. Semin Intervent Radiol (2012) 0.78
Percutaneous transhepatic sclerotherapy with embolization of the drainage vein for a gastric varix. Acta Radiol Short Rep (2014) 0.78
The role of divided injections of a sclerotic agent over two days in balloon-occluded retrograde transvenous obliteration for large gastric varices. Korean J Radiol (2013) 0.78
Ruptured high flow gastric varices with an intratumoral arterioportal shunt treated with balloon-occluded retrograde transvenous obliteration during temporary balloon occlusion of a hepatic artery. World J Gastroenterol (2006) 0.78
Balloon-occluded retrograde transvenous obliteration for gastric varices via the intercostal vein. World J Radiol (2012) 0.78
Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technique and Intraprocedural Imaging. Semin Intervent Radiol (2011) 0.76
Hemodynamic effects of combined therapy using partial splenic embolization and transjugular retrograde obliteration for gastric varices with gastrorenal shunt. World J Surg (2010) 0.76
Anatomy and classification of gastrorenal and gastrocaval shunts. Semin Intervent Radiol (2011) 0.76
Treatment of bleeding stomal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol (2007) 0.76
The secondary prophylactic efficacy of beta-blocker after endoscopic gastric variceal obturation for first acute episode of gastric variceal bleeding. Clin Mol Hepatol (2013) 0.75
Factors associated with aggravation of esophageal varices after B-RTO for gastric varices. Cardiovasc Intervent Radiol (2013) 0.75
Ileal Varices Treated with Balloon-Occluded Retrograde Transvenous Obliteration. Gastroenterology Res (2009) 0.75
Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for gastric fundal varices. United European Gastroenterol J (2015) 0.75
Efficacy and Safety of Balloon-Occluded Retrograde Transvenous Obliteration with Sodium Tetradecyl Sulfate Liquid Sclerotherapy. Korean J Radiol (2016) 0.75
Percutaneous transhepatic obliteration and percutaneous transhepatic sclerotherapy for intractable hepatic encephalopathy and gastric varices improves the hepatic function reserve. Biomed Rep (2016) 0.75
Endoscopic color Doppler ultrasonography for esophagogastric varices. Diagn Ther Endosc (2012) 0.75
Vascular Plug Assisted Retrograde Transvenous Obliteration (PARTO) for Gastric Varix Bleeding Patients in the Emergent Clinical Setting. Yonsei Med J (2016) 0.75
Nonendoscopic management strategies for acute esophagogastric variceal bleeding. Gastroenterol Clin North Am (2014) 0.75
Splenic artery embolization and balloon occlusion retrograde alcohol embolization in a patient with bleeding gastric varices. Semin Intervent Radiol (2007) 0.75
Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Follow-Up and Postprocedural Imaging. Semin Intervent Radiol (2011) 0.75
Management of rectal varices in portal hypertension. World J Hepatol (2015) 0.75
Treatment of ectopic varices with portal hypertension. World J Hepatol (2015) 0.75
A case of complete resolution of gastric varices. Nat Rev Gastroenterol Hepatol (2009) 0.75
Balloon-occluded retrograde transvenous obliteration successfully performed for a large gastric varix in combination with temporary occlusion of the splenic artery in a child. Acta Radiol Open (2015) 0.75
Balloon occluded retrograde transvenous obliteration for bleeding gastric varices: Eyes see what the mind knows. Indian J Radiol Imaging (2017) 0.75
Dual microcatheter retrograde transvenous obliteration of gastric varices: coil embolization as a substitute for balloon occlusion. Case Rep Gastroenterol (2012) 0.75
Visualization of gastric varices using angiographic C-arm CT during retrograde transvenous sclerotherapy. Indian J Radiol Imaging (2010) 0.75
Changes in liver perfusion and function before and after percutaneous occlusion of spontaneous portosystemic shunt. Jpn J Radiol (2017) 0.75
Successful balloon-occluded retrograde transvenous obliteration for ruptured gastric fundal varices in a patient with Child-Pugh C cirrhosis: case report and literature review. Dig Dis Sci (2004) 0.75
Efficacy and safety of balloon-occluded retrograde transvenous obliteration for gastric fundal varices in children. Pediatr Surg Int (2008) 0.75
An Algorithm for Management After Transjugular Intrahepatic Portosystemic Shunt Placement According to Clinical Manifestations. Dig Dis Sci (2017) 0.75
Inflammatory tumor in pancreas: a novel complication after endoscopic injection of cyanoacrylate for gastric fundal varices. J Gastroenterol (2005) 0.75
A case of spontaneous splenorenal shunt associated with splenic artery aneurysm. Surg Radiol Anat (2006) 0.75
Efficacy of color Doppler ultrasonography for the diagnosis of duodenal varices successfully treated with percutaneous transhepatic obliteration. J Med Ultrason (2001) (2007) 0.75
Gastric ulcer after prophylactic balloon-occluded retrograde transvenous obliteration. J Gastroenterol (2007) 0.75
Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan. J Am Coll Cardiol (2001) 12.56
[Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases]. J Cardiol (1991) 7.95
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer (1985) 7.67
The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem (2000) 7.41
Conservation of primary structure in 16S ribosomal RNA. Nature (1975) 5.88
The use of ribonuclease U2 in RNA sequence determination. Some corrections in the catalog of oligomers produced by ribonuclease T1 digestion of Escherichia coli 16S ribosomal RNA. J Mol Evol (1974) 5.26
THE DISTRIBUTION IN THE HUMAN BODY OF SPIROCHAETA ICTEROHAEMORRHAGIAE. J Exp Med (1917) 4.80
Mutation in the structural gene for diphtheria toxin carried by temperate phage . Nat New Biol (1971) 4.67
Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension (2001) 4.07
One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell (1978) 4.06
Diphtheria toxin and related proteins. I. Isolation and properties of mutant proteins serologically related to diphtheria toxin. J Biol Chem (1973) 3.78
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55
An immunological study of the diphtheria toxin molecule. Immunochemistry (1972) 3.48
Propensity of ectopic liver to hepatocarcinogenesis: case reports and a review of the literature. Hepatology (1999) 3.29
Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years. Cancer (1983) 3.28
Electric and magnetic phenomena observed before the volcano-seismic activity in 2000 in the Izu Island Region, Japan. Proc Natl Acad Sci U S A (2002) 3.18
Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med (1996) 3.13
Isolation from corynebacterium diphtheriae C7(beta) of bacterial mutants that produce toxin in medium with excess iron. Infect Immun (1977) 3.12
Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11
Nonsurgical, percutaneous transhepatic cholangiography--diagnostic significance in medical problems of the liver. Am J Dig Dis (1974) 3.09
Editorial: The First Specialist Qualification Examination of the Japanese Society of Intravascular Neurosurgery (JSIN). Interv Neuroradiol (2004) 3.03
Reversible inhibition of protein import into the nucleus by wheat germ agglutinin injected into cultured cells. Exp Cell Res (1987) 2.75
Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology (1997) 2.67
Characterization of genes in the cellulose-synthesizing operon (acs operon) of Acetobacter xylinum: implications for cellulose crystallization. J Bacteriol (1994) 2.49
Phage particle-mediated gene transfer to cultured mammalian cells. Mol Cell Biol (1982) 2.47
KRN7000, a novel immunomodulator, and its antitumor activities. Oncol Res (1995) 2.43
NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol (1994) 2.40
Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol (2008) 2.37
A CONTRIBUTION TO THE ETIOLOGY AND PATHOLOGY OF RAT-BITE FEVER. J Exp Med (1917) 2.36
Binding properties of monoclonal antibody to the cytoplasmic domain of transferrin receptor. Cell Struct Funct (1988) 2.36
Haemagglutinating activity of Bacteroides melaninogenicus. Arch Oral Biol (1974) 2.35
Percutaneous transhepatic drainage of the biliary tract: technique and results in 104 cases. Gastroenterology (1978) 2.27
Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology (1988) 2.26
Inflammatory pseudotumor of the liver. Clinicopathologic study and review of the literature. Cancer (1990) 2.26
Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol (1997) 2.25
Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood (1994) 2.16
The long-term pathological evolution of chronic hepatitis C. Hepatology (1996) 2.15
Ribonuclease preparation for the base analysis of polyribonucleotides. Anal Biochem (1966) 2.11
Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology (1985) 2.11
Expression levels of DNA methyltransferase genes do not correlate with p15INK4B gene methylation in myelodysplastic syndromes. Leukemia (2003) 2.06
Induction of cell-membrane porosity by ultrasound. Lancet (1999) 2.06
Quasiperiodicity and chaos in cardiac fibrillation. J Clin Invest (1997) 1.99
Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Exp Hematol (1993) 1.98
Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation. Antimicrob Agents Chemother (2001) 1.96
Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union. Gastroenterology (1985) 1.92
A recB recC sbcB recJ host prevents recA-independent deletions in recombinant cosmid DNA propagated in Escherichia coli. J Bacteriol (1989) 1.90
Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China. Nucleic Acids Res (1992) 1.89
Diphtheria toxin, protein synthesis, and the cell. Fed Proc (1973) 1.87
Diphtheria toxin and related proteins. II. Kinetic studies on intoxication of HeLa cells by diphtheria toxin and related proteins. J Biol Chem (1973) 1.87
Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science (1989) 1.86
BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity (2000) 1.86
Expression of diphtheria toxin genes carried by integrated and nonintegrated phage beta. Virology (1972) 1.86
Histopathology of membranous obstruction of the inferior vena cava in the Budd-Chiari syndrome. Gastroenterology (1992) 1.85
Purification and properties of hemagglutinin from culture supernatant of Bacteroides gingivalis. Infect Immun (1986) 1.85
Reconstitution of diphtheria toxin from two nontoxic cross-reacting mutant proteins. Science (1972) 1.82
Intrinsic properties of reverse transcriptase in reverse transcription. Associated RNase H is essentially regarded as an endonuclease. J Biol Chem (1989) 1.82
Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord (1993) 1.82
Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology (1986) 1.76
Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochem Biophys Res Commun (1999) 1.73
Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia. Blood (1994) 1.72
Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci U S A (1989) 1.69
Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett (1993) 1.67
Amino acid sequence of mammalian elongation factor 2 deduced from the cDNA sequence: homology with GTP-binding proteins. Proc Natl Acad Sci U S A (1986) 1.64
CIRCULATING IMMUNITY PRINCIPLES IN RAT-BITE FEVER. J Exp Med (1917) 1.64
Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions. J Biol Chem (1996) 1.63
Early recognition of hepatocellular carcinoma. Hepatology (1986) 1.62
Thermophilic DNA ligase. Purification and properties of the enzyme from Thermus thermophilus HB8. J Biol Chem (1984) 1.61
Regional assignment of five genes on human chromosome 19. Chromosoma (1987) 1.60
Role of oxygen-derived free radicals in myocardial edema and ischemia in coronary microvascular embolization. Circulation (1991) 1.60
Antibodies to Asp-Asp-Glu-Asp can inhibit transport of nuclear proteins into the nucleus. Science (1988) 1.60
A technique of cervical aortic graft transplantation in mice. J Heart Lung Transplant (2001) 1.59
High incidence of several malformations in the early human embryos as compared with infants. Biol Neonat (1966) 1.58
Affinity chromatography of protein kinase C-phorbol ester receptor on polyacrylamide-immobilized phosphatidylserine. J Biol Chem (1984) 1.57
Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification. Cancer (1984) 1.57
Diphtheria toxin and related proteins. 3. Reconstitution of hybrid "diphtheria toxin" from nontoxic mutant proteins. J Biol Chem (1973) 1.55
Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective. J Gastroenterol Hepatol (1999) 1.54
Expression of cytokines after meniscal rasping to promote meniscal healing. Arthroscopy (2001) 1.53
Structural gene and complete amino acid sequence of Pseudomonas aeruginosa IFO 3455 elastase. J Bacteriol (1989) 1.51
Studies on extracellular ribonucleases of Ustilago sphaerogena. Characterization of substrate specificity with special reference to purine-specific ribonucleases. Biochem J (1968) 1.51
Isolation of a new human fetal liver cytochrome P450 cDNA clone: evidence for expression of a limited number of forms of cytochrome P450 in human fetal livers. Arch Biochem Biophys (1989) 1.49
The extent of lymph node dissection for colon carcinoma: the potential impact on laparoscopic surgery. Cancer (1997) 1.49
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer (1977) 1.49
Relative frequencies of portosystemic pathways and renal shunt formation through the "posterior" gastric vein: portographic study in 460 patients. Hepatology (1990) 1.48
Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J Immunol (1997) 1.48
High-performance liquid chromatographic assay of serum glycated albumin. Diabetologia (1988) 1.47
Purification, characterization, and cloning of enamel matrix serine proteinase 1. J Dent Res (1998) 1.46
HVJ (Sendai virus)-induced envelope fusion and cell fusion are blocked by monoclonal anti-HN protein antibody that does not inhibit hemagglutination activity of HVJ. Exp Cell Res (1982) 1.46
Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. XI. Pseudogenetic restrictions of hybridoma suppressor factors. J Exp Med (1981) 1.46
Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. J Biol Chem (1992) 1.45
Salivary bisphenol-A levels detected by ELISA after restoration with composite resin. J Mater Sci Mater Med (2005) 1.45
Validation in volunteers of a near-infrared spectroscope for monitoring brain oxygenation in vivo. Anesth Analg (1996) 1.44
Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol (1996) 1.44
Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol (1995) 1.44
Changing incidence of hepatocellular carcinoma in Japan. Cancer Res (1987) 1.44
Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. J Biol Chem (1994) 1.43
Characterization of the Treponema denticola prtP gene encoding a prolyl-phenylalanine-specific protease (dentilisin). Infect Immun (1996) 1.43
Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosis. Cell Death Differ (2004) 1.43
Rat liver cholesterol 7 alpha-hydroxylase. Pretranslational regulation for circadian rhythm. J Biol Chem (1990) 1.43
Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology (1984) 1.43